QR Code

Successful treatment of a case of hypereosinophilia with suplatast tosilate monotherapy

Background: Hypereosinophilia (HE) is a rare disease characterized by an increase in eosinophils. Suplatast tosilate is a selective Th2 cytokine inhibitor. This case report presents the course and prognosis of a patient with hypereosinophilia treated with suplatast tosilate monotherapy. Case present...

Full description

Saved in:
Main Authors: Yongshi Yang, Yali Cheng, Jing Zhang, Lu Lyu, Jinlyu Sun
Format: Artigo
Language:Inglês
Published: Elsevier 2025-06-01
Series:Allergy Medicine
Subjects:
Eosinophil
Hypereosinophilia
Suplatast tosilate
Th2 cytokine inhibitor
Monotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2949913524000272
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items